Developer docs
API playgroundTry for free, no card

Search company profiles

Aspira Pathlab & Diagnostics

Full company profile

uuid003n1y2

Namestring
Aspira Pathlab & Diagnostics
Legal namestring
Aspira Pathlab & Diagnostics Limited
Company typeenum
Public
Founded yearint
2015
Descriptiontext

Aspira Pathlab & Diagnostics is a BSE-listed Indian diagnostic chain (scrip: ASPIRA), headquartered in the Mumbai Metropolitan Region and operating 18-20+ NABL-accredited centres across Ghatkopar, Mumbai, Navi Mumbai, Thane, Surat, Nashik and Navsari. The company traces its operating lineage to 1991 in Ghatkopar, although listed-entity firmographic records indicate a 2015 incorporation. Aspira offers a broad test menu of more than 1,100 pathology tests, 71+ sonography protocols and 177+ X-ray types, positioning it as a multi-modality diagnostics provider rather than a single-test specialty lab.

The business model is primarily direct-to-consumer and walk-in, supplemented by referrals from neighbourhood clinicians. Centres operate as physical collection-and-reporting nodes feeding centralized processing; revenue is generated per-test rather than via subscription or enterprise contracts. Aspira is a small-cap public entity with 101-250 employees and quarterly disclosed topline figures in the Rs 5-7 crore range, implying annualized revenue of roughly Rs 22-26 crore (US$2.6-3.1M). The company is currently navigating a corporate-action phase: an Open Offer was launched for fiscal year 2025-2026 and multiple senior leadership resignations occurred during 2026, while FY2026 results showed a 97.58% YoY collapse in net profit and an operating margin of approximately -23.63% despite 13.55% YoY sales growth.

Short descriptiontext

Aspira Pathlab & Diagnostics is a BSE-listed Indian diagnostic chain operating 18-20+ NABL-accredited centres across Mumbai, Navi Mumbai, Thane, Surat, Nashik and Navsari, offering 1,100+ pathology tests plus sonography and X-ray services to walk-in retail patients and clinician referrals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices24 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pathology testing services, diagnostic health packages, radiology imaging services, clinical laboratory diagnostics, preventive health screening
Industry3 codes
PRIMARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHSABACAN
Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home)
Home & Personal Services/Elder Care & In-Home Care Services/Skilled Nursing & Clinical Home Health
NAICS code3 codes
  • Medical and Diagnostic Laboratories62151
  • Medical Laboratories621511
  • Diagnostic Imaging Centers621512
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diagnostic Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Diagnostic Testing Services
TypeOne Time License
Description

One-time transaction-based revenue from individual pathology tests, radiology services (X-Ray, Sonography), and health packages. Patients pay per test or package at point of service.

aspiradiagnostics.com
2Health Packages
TypeOne Time License
Description

Predefined health screening packages (e.g., Aspira Totus, Aspira Diabetes Amulya, cardiac profiles) sold as one-time purchases with bundled test combinations.

aspiradiagnostics.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details8 tiers
1Individual Pathology Tests - Entry Level
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Basic tests starting from ₹500 (e.g., SARS-CoV-2 RT-PCR ₹500, CRP ₹550, HIV test ₹580). Most individual tests range from ₹500 to ₹5,500.

aspiradiagnostics.com
2Individual Pathology Tests - Premium
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Specialized PCR and advanced tests ranging from ₹5,500 to ₹16,900 (e.g., FilmArray BCID Panel ₹16,900, Influenza Panel ₹5,500).

aspiradiagnostics.com
3Health Packages - Basic
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Entry-level health packages from ₹950 (Aspira Aarambh) to ₹2,100 (Aspira Diabetes Amulya Monitoring).

aspiradiagnostics.com
4Health Packages - Comprehensive
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Comprehensive health packages from ₹2,100 to ₹12,200 (e.g., Aspira Imperia Male ₹12,200, Ultra Smart Package ₹7,400).

aspiradiagnostics.com
5Gynecology & Specialized Profiles
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Fertility and antenatal profiles ranging from ₹1,700 to ₹11,100 (e.g., Infertility Profile Female ₹5,200, BOH Profile Extended ₹11,100).

aspiradiagnostics.com
6Coagulation & Thrombosis Panels
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Specialized coagulation panels from ₹2,300 to ₹17,850 (e.g., Thrombophilia Profile-1 ₹17,850, Thrombotic Profile ₹15,970).

aspiradiagnostics.com
7Sonography Services
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Ultrasound and Doppler studies ranging from ₹350 (1-day follicular study) to ₹5,200 (Venous Doppler both upper limbs).

aspiradiagnostics.com
8X-Ray Services
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual X-ray studies from ₹380 to ₹850 depending on complexity and body part.

aspiradiagnostics.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 11 records shown
1AspiraHealth App
Description

Mobile application for booking appointments, ordering tests at home, monitoring test results, and accessing complete diagnostic history.

aspiradiagnostics.com
+10 more records
Core offering1 text field

Aspira Pathlab & Diagnostics Limited operates an NABL-accredited diagnostic laboratory chain in Mumbai offering 1,100+ pathology tests across 20+ specialty categories, sonography and X-ray imaging, and a portfolio of preventive health checkup packages delivered through 18+ advanced labs and 20+ collection centers. Services are accessed by walk-in patients, through home visit sample collection, and via the AspiraHealth mobile app.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Same-day report delivery for applicable tests
Product overview1 text field

Aspira Pathlab & Diagnostics operates as a multi-modality diagnostic laboratory network offering pathology testing, sonography, and X-ray imaging services. The core offering includes over 1,100 pathology tests and 71+ sonography services complemented by comprehensive health screening packages under the Aspira brand family (Totus, Totus Plus, Diabetes Amulya, Vitae, Sampurnam, Imperia, Prius, Aarambh). Specialized panels cover oncology, cardiology, women's health, newborn screening, coagulation, and allergy testing. The company distributes its services through a network of 18+ advanced clinical labs and collection centers across Mumbai, with home visit phlebotomy services and a digital platform (Aspira Health app) enabling patient self-service for appointments, test booking, and report access.

Product and service13 records
1Pathology Diagnostics Services
CategoryPathology Testing
Description

NABL-accredited pathology testing covering 1,100+ tests across categories such as diabetes, cardiac, lipid, liver, kidney, CBC, cancer markers, thyroid, vitamins, allergens, fever, hormones, pregnancy, bone, toxicology, STD, COVID, dengue, malaria and typhoid, delivered to walk-in and home-collection patients in Mumbai.

2Sonography and X-Ray Imaging
CategoryRadiology Imaging
Description

Radiology imaging services (sonography and X-ray) provided at Aspira's clinical labs and collection centers for patients referred for imaging workups alongside or independent of pathology testing.

3Totus - Full Body Health Checkup Package
CategoryPreventive Health Package
Description

Comprehensive preventive full-body health checkup package bundling multiple pathology tests across major organ systems for individuals seeking a single annual screening solution.

4Diabetes Amulya Package
CategoryPreventive Health Package
Description

Diabetes-focused preventive health package bundling glycemic, lipid, kidney and related markers for patients screening for or managing diabetes.

5Monsoon Profile Package
CategoryPreventive Health Package
Description

Seasonal monsoon-focused health package bundling tests for fever, vector-borne and water-borne conditions such as dengue, malaria and typhoid relevant to the Indian monsoon season.

6Cardiac Health Package
CategoryPreventive Health Package
Description

Cardiac-focused preventive health package bundling lipid profile, cardiac risk markers and related tests for cardiovascular screening.

7Cancer Screening Package
CategoryPreventive Health Package
Description

Cancer screening preventive health package bundling tumor markers and related diagnostic tests for early cancer risk screening.

8Fever Package
CategoryPreventive Health Package
Description

Fever-focused diagnostic package bundling tests relevant to evaluating febrile illness for patients presenting with fever symptoms.

9Covid Care Package
CategoryPreventive Health Package
Description

COVID-focused diagnostic package bundling COVID-related testing and supportive markers for patients screening or monitoring COVID-19.

10Health Package Female
CategoryPreventive Health Package
Description

Gender-specific women's preventive health checkup package bundling tests relevant to female health screening.

11Health Package Male
CategoryPreventive Health Package
Description

Gender-specific men's preventive health checkup package bundling tests relevant to male health screening.

12Health Package Senior
CategoryPreventive Health Package
Description

Age-specific senior citizen preventive health checkup package bundling tests relevant to geriatric screening.

13Health Package Basic
CategoryPreventive Health Package
Description

Entry-level basic preventive health checkup package bundling a core set of routine screening tests for first-time or cost-conscious users.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Dr. Lal PathLabs Limited
TypeDirect peer
Description

India's largest listed diagnostic chain offering pathology, radiology, and preventive health packages across India with NABL-accredited labs and home sample collection. Directly comparable to Aspira on services, NABL accreditation, and home collection, but at vastly greater national scale.

2Metropolis Healthcare Limited
TypeDirect peer
Description

Pan-India diagnostic chain with NABL/CAP accredited labs, extensive test menu, and growing presence in Mumbai. Closely comparable business model to Aspira across pathology, radiology, and preventive health packages.

3Thyrocare Technologies Limited
TypeDirect peer
Description

Listed Indian diagnostic chain operating a centralized processing model with B2B partner network (including franchisee collection centres). Comparable to Aspira's automated-lab + franchisee hub-and-spoke architecture, though Thyrocare is B2B-led.

4Agilus Diagnostics (formerly SRL Diagnostics)
TypeDirect peer
Description

One of India's largest diagnostic networks, part of the Fortis/Agilus group, offering pathology and radiology services with home sample collection. Direct competitor for Aspira, especially in Mumbai and western India.

5Suburban Diagnostics
TypeDirect peer
Description

Long-standing Mumbai-based diagnostic chain with pathology, radiology, and home visit services. Head-to-head competitor for Aspira in Mumbai metro with overlapping service mix and target customers.

6Neuberg Diagnostics
TypeDirect peer
Description

Pan-India diagnostic chain with NABL/NABL-MELT accredited labs offering pathology and integrated diagnostics. Comparable NABL-accredited B2C and B2B diagnostic services, though larger and more geographically diverse than Aspira.

7Apollo Diagnostics
TypeBroad incumbent
Description

Diagnostics arm of Apollo Hospitals, offering pathology, radiology, and preventive health packages nationally. Overlapping services with Aspira but operating as part of a much larger hospital group, providing brand and integration advantages.

8Tata 1mg Labs (1mg Technologies)
TypeEmerging player
Description

Digital health platform offering diagnostic test booking, home sample collection, and online report delivery. Comparable to Aspira's home-collection + digital-booking model, but with stronger digital marketing and aggregation capabilities.

9PharmEasy (Thyrocare-parent subsidiary)
TypeEmerging player
Description

Online pharmacy and diagnostic aggregator offering home sample collection partnered with Thyrocare and other labs. As a digital aggregator, it both competes with and offers a distribution channel for local labs like Aspira.

10Vijaya Diagnostic Centre
TypeRegional player
Description

South India-focused diagnostic chain with NABL-accredited labs and radiology services. Comparable in services and accreditation to Aspira, but primarily serves Hyderabad and Telangana/AP rather than Mumbai.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aspira Pathlab & Diagnostics

Diagnostic Laboratory Servicesaspiradiagnostics.com

Aspira Pathlab & Diagnostics is a BSE-listed Indian diagnostic chain operating 18-20+ NABL-accredited centres across Mumbai, Navi Mumbai, Thane, Surat, Nashik and Navsari, offering 1,100+ pathology tests plus sonography and X-ray services to walk-in retail patients and clinician referrals.

What Aspira Pathlab & Diagnostics does

Aspira Pathlab & Diagnostics is a BSE-listed Indian diagnostic chain (scrip: ASPIRA), headquartered in the Mumbai Metropolitan Region and operating 18-20+ NABL-accredited centres across Ghatkopar, Mumbai, Navi Mumbai, Thane, Surat, Nashik and Navsari. The company traces its operating lineage to 1991 in Ghatkopar, although listed-entity firmographic records indicate a 2015 incorporation. Aspira offers a broad test menu of more than 1,100 pathology tests, 71+ sonography protocols and 177+ X-ray types, positioning it as a multi-modality diagnostics provider rather than a single-test specialty lab.

The business model is primarily direct-to-consumer and walk-in, supplemented by referrals from neighbourhood clinicians. Centres operate as physical collection-and-reporting nodes feeding centralized processing; revenue is generated per-test rather than via subscription or enterprise contracts. Aspira is a small-cap public entity with 101-250 employees and quarterly disclosed topline figures in the Rs 5-7 crore range, implying annualized revenue of roughly Rs 22-26 crore (US$2.6-3.1M). The company is currently navigating a corporate-action phase: an Open Offer was launched for fiscal year 2025-2026 and multiple senior leadership resignations occurred during 2026, while FY2026 results showed a 97.58% YoY collapse in net profit and an operating margin of approximately -23.63% despite 13.55% YoY sales growth.

Aspira Pathlab & Diagnostics firmographics

Firmographics
Name
Aspira Pathlab & Diagnostics
Legal name
Aspira Pathlab & Diagnostics Limited
Website
https://aspiradiagnostics.com
Company type
Public
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Short description
Aspira Pathlab & Diagnostics is a BSE-listed Indian diagnostic chain operating 18-20+ NABL-accredited centres across Mumbai, Navi Mumbai, Thane, Surat, Nashik and Navsari, offering 1,100+ pathology tests plus sonography and X-ray services to walk-in retail patients and clinician referrals.
Ownership category
akta.pro rank

Aspira Pathlab & Diagnostics industry classification

Industry
Product category
Diagnostic Laboratory Services
NAICS
Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Diagnostic Imaging Centers (621512)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHSABACAN
Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home)
Home & Personal Services/Elder Care & In-Home Care Services/Skilled Nursing & Clinical Home Health

Keywords

  • Pathology testing services
  • Diagnostic health packages
  • Radiology imaging services
  • Clinical laboratory diagnostics
  • Preventive health screening

Where Aspira Pathlab & Diagnostics is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices24 records

Markets served

Aspira Pathlab & Diagnostics business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Diagnostic Testing Services: One-time transaction-based revenue from individual pathology tests, radiology services (X-Ray, Sonography), and health packages. Patients pay per test or package at point of service.
  2. Health Packages: Predefined health screening packages (e.g., Aspira Totus, Aspira Diabetes Amulya, cardiac profiles) sold as one-time purchases with bundled test combinations.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual Pathology Tests - Entry Level
Unit PricingPay-as-you-goIndividual Pathology Tests - Premium
Unit PricingPay-as-you-goHealth Packages - Basic
Unit PricingPay-as-you-goHealth Packages - Comprehensive
Unit PricingPay-as-you-goGynecology & Specialized Profiles
Unit PricingPay-as-you-goCoagulation & Thrombosis Panels
Unit PricingPay-as-you-goSonography Services
Unit PricingPay-as-you-goX-Ray Services

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Aspira Pathlab & Diagnostics product offering

Product offering

Core offering

Aspira Pathlab & Diagnostics Limited operates an NABL-accredited diagnostic laboratory chain in Mumbai offering 1,100+ pathology tests across 20+ specialty categories, sonography and X-ray imaging, and a portfolio of preventive health checkup packages delivered through 18+ advanced labs and 20+ collection centers. Services are accessed by walk-in patients, through home visit sample collection, and via the AspiraHealth mobile app.

Product overview

Aspira Pathlab & Diagnostics operates as a multi-modality diagnostic laboratory network offering pathology testing, sonography, and X-ray imaging services. The core offering includes over 1,100 pathology tests and 71+ sonography services complemented by comprehensive health screening packages under the Aspira brand family (Totus, Totus Plus, Diabetes Amulya, Vitae, Sampurnam, Imperia, Prius, Aarambh). Specialized panels cover oncology, cardiology, women's health, newborn screening, coagulation, and allergy testing. The company distributes its services through a network of 18+ advanced clinical labs and collection centers across Mumbai, with home visit phlebotomy services and a digital platform (Aspira Health app) enabling patient self-service for appointments, test booking, and report access.

Differentiator

Problem solved

Functional benefit

Brands

  • AspiraHealth App: Mobile application for booking appointments, ordering tests at home, monitoring test results, and accessing complete diagnostic history.
  • Aspira Aarambh
  • Aspira Totus
  • Aspira Totus Plus
  • Aspira Imperia
  • Aspira Prius
  • Aspira Sampurnam
  • Aspira Diabetes Amulya
  • Aspira Vitae
  • Ultra Smart Package
  • Aspira Monsoon Profiles

Products and services

  • Pathology Diagnostics Services NABL-accredited pathology testing covering 1,100+ tests across categories such as diabetes, cardiac, lipid, liver, kidney, CBC, cancer markers, thyroid, vitamins, allergens, fever, hormones, pregnancy, bone, toxicology, STD, COVID, dengue, malaria and typhoid, delivered to walk-in and home-collection patients in Mumbai.
  • Sonography and X-Ray Imaging Radiology imaging services (sonography and X-ray) provided at Aspira's clinical labs and collection centers for patients referred for imaging workups alongside or independent of pathology testing.
  • Totus - Full Body Health Checkup Package Comprehensive preventive full-body health checkup package bundling multiple pathology tests across major organ systems for individuals seeking a single annual screening solution.
  • Diabetes Amulya Package Diabetes-focused preventive health package bundling glycemic, lipid, kidney and related markers for patients screening for or managing diabetes.
  • Monsoon Profile Package Seasonal monsoon-focused health package bundling tests for fever, vector-borne and water-borne conditions such as dengue, malaria and typhoid relevant to the Indian monsoon season.
  • Cardiac Health Package Cardiac-focused preventive health package bundling lipid profile, cardiac risk markers and related tests for cardiovascular screening.
  • Cancer Screening Package Cancer screening preventive health package bundling tumor markers and related diagnostic tests for early cancer risk screening.
  • Fever Package Fever-focused diagnostic package bundling tests relevant to evaluating febrile illness for patients presenting with fever symptoms.
  • Covid Care Package COVID-focused diagnostic package bundling COVID-related testing and supportive markers for patients screening or monitoring COVID-19.
  • Health Package Female Gender-specific women's preventive health checkup package bundling tests relevant to female health screening.
  • Health Package Male Gender-specific men's preventive health checkup package bundling tests relevant to male health screening.
  • Health Package Senior Age-specific senior citizen preventive health checkup package bundling tests relevant to geriatric screening.
  • Health Package Basic Entry-level basic preventive health checkup package bundling a core set of routine screening tests for first-time or cost-conscious users.

Quantifiable outcome

  • Same-day report delivery for applicable tests

Companies that use Aspira Pathlab & Diagnostics

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Aspira Pathlab & Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature3 records

Aspira Pathlab & Diagnostics partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves9 records

Expansion highlights4 records

Aspira Pathlab & Diagnostics competitors and assessment

Company assessment

Direct peers

  • Dr. Lal PathLabs Limited: India's largest listed diagnostic chain offering pathology, radiology, and preventive health packages across India with NABL-accredited labs and home sample collection. Directly comparable to Aspira on services, NABL accreditation, and home collection, but at vastly greater national scale.
  • Metropolis Healthcare Limited: Pan-India diagnostic chain with NABL/CAP accredited labs, extensive test menu, and growing presence in Mumbai. Closely comparable business model to Aspira across pathology, radiology, and preventive health packages.
  • Thyrocare Technologies Limited: Listed Indian diagnostic chain operating a centralized processing model with B2B partner network (including franchisee collection centres). Comparable to Aspira's automated-lab + franchisee hub-and-spoke architecture, though Thyrocare is B2B-led.
  • Agilus Diagnostics (formerly SRL Diagnostics): One of India's largest diagnostic networks, part of the Fortis/Agilus group, offering pathology and radiology services with home sample collection. Direct competitor for Aspira, especially in Mumbai and western India.
  • Suburban Diagnostics: Long-standing Mumbai-based diagnostic chain with pathology, radiology, and home visit services. Head-to-head competitor for Aspira in Mumbai metro with overlapping service mix and target customers.
  • Neuberg Diagnostics: Pan-India diagnostic chain with NABL/NABL-MELT accredited labs offering pathology and integrated diagnostics. Comparable NABL-accredited B2C and B2B diagnostic services, though larger and more geographically diverse than Aspira.

Broad incumbents

  • Apollo Diagnostics: Diagnostics arm of Apollo Hospitals, offering pathology, radiology, and preventive health packages nationally. Overlapping services with Aspira but operating as part of a much larger hospital group, providing brand and integration advantages.

Emerging players

  • Tata 1mg Labs (1mg Technologies): Digital health platform offering diagnostic test booking, home sample collection, and online report delivery. Comparable to Aspira's home-collection + digital-booking model, but with stronger digital marketing and aggregation capabilities.
  • PharmEasy (Thyrocare-parent subsidiary): Online pharmacy and diagnostic aggregator offering home sample collection partnered with Thyrocare and other labs. As a digital aggregator, it both competes with and offers a distribution channel for local labs like Aspira.

Regional players

  • Vijaya Diagnostic Centre: South India-focused diagnostic chain with NABL-accredited labs and radiology services. Comparable in services and accreditation to Aspira, but primarily serves Hyderabad and Telangana/AP rather than Mumbai.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Aspira Pathlab & Diagnostics social profiles

Digital presence

Aspira Pathlab & Diagnostics compliance and trust

Trust signal

Compliance2 records

Aspira Pathlab & Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aspira Pathlab & Diagnostics leadership team

Management profile

Number of profiles

Profiles4 records

Aspira Pathlab & Diagnostics subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Aspira Pathlab & Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aspira Pathlab & Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aspira Pathlab & Diagnostics

What does Aspira Pathlab & Diagnostics do?

Aspira Pathlab & Diagnostics Limited operates an NABL-accredited diagnostic laboratory chain in Mumbai offering 1,100+ pathology tests across 20+ specialty categories, sonography and X-ray imaging, and a portfolio of preventive health checkup packages delivered through 18+ advanced labs and 20+ collection centers. Services are accessed by walk-in patients, through home visit sample collection, and via the AspiraHealth mobile app.

Is Aspira Pathlab & Diagnostics a public or private company?

Aspira Pathlab & Diagnostics is a public company. It is classified as public and is currently operating.

When was Aspira Pathlab & Diagnostics founded?

Aspira Pathlab & Diagnostics was founded in 2015. It employs 101 to 250 people.

Where is Aspira Pathlab & Diagnostics based?

Aspira Pathlab & Diagnostics is headquartered in Mumbai, India, in the Asia region.

How does Aspira Pathlab & Diagnostics make money?

Two revenue lines are on record. Diagnostic Testing Services are the primary driver. The others are health Packages.

Who are Aspira Pathlab & Diagnostics's main competitors?

Direct peers on record are Dr. Lal PathLabs Limited, Metropolis Healthcare Limited, Thyrocare Technologies Limited, Agilus Diagnostics (formerly SRL Diagnostics), Suburban Diagnostics and Neuberg Diagnostics. Apollo Diagnostics is listed as a broad incumbent. Emerging players are Tata 1mg Labs (1mg Technologies) and PharmEasy (Thyrocare-parent subsidiary). Vijaya Diagnostic Centre is listed as a regional player.

Does Aspira Pathlab & Diagnostics have an API?

No public API is recorded for Aspira Pathlab & Diagnostics.

What industry is Aspira Pathlab & Diagnostics in?

Aspira Pathlab & Diagnostics's product category is Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support), with a secondary code of HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXAspira Pathlab & Diagnostics promoter lifts stake to 7.31% via open marketPromoter Jay Arvind Bhanushali acquired 1,599 shares of Aspira Pathlab & Diagnostics via open market on November 13, 2026, raising his stake to 7.31%. The holding increased from 7,50,796 to 7,52,395 shares, with total share capital unchanged at ₹10,29,30,000. No encumbered shares were reported before or after the transaction.ScanXAspira Pathlab & Diagnostics promoter Jay Arvind Bhanushali buys 1,289 sharesPromoter Jay Arvind Bhanushali bought 1,289 shares of Aspira Pathlab & Diagnostics on November 12, 2026, raising his stake to 7.29% from 7.28%. The acquisition was made via open market, with no encumbered shares. The filing was made under SEBI regulations.ScanXAspira Pathlab promoter Jay Arvind Bhanushali acquires 957 sharesPromoter Jay Arvind Bhanushali acquired 957 equity shares of Aspira Pathlab on August 31, 2026, via open market transactions. His stake rose from 7.24% to 7.25%, with total holding increasing from 7,44,797 to 7,45,754 shares. The acquisition was disclosed under SEBI SAST Regulation 29(2).Business StandardAspira Pathlab & Diagnostics reports standalone net loss of Rs 0.04 crore in the June 2026 quarterAspira Pathlab & Diagnostics reported a standalone net loss of Rs 0.04 crore for the quarter ended June 2026, reversing from a net profit of Rs 0.47 crore in the same period last year. This decline occurred despite sales rising 17.52% to Rs 6.17 crore, driven by a significant drop in operating profit margin and pre-tax earnings.ScanXAspira Pathlab internal auditor resigns on Aug 13M/s. Vishal J Bhanushali and Associates resigned as Internal Auditor of Aspira Pathlab & Diagnostics Ltd, effective August 13, 2026, citing preoccupation and personal reasons. The company disclosed this resignation under SEBI LODR Regulation 30, which mandates prompt disclosure of material corporate events by listed entities.ScanXAspira Pathlab accepts Vaibhav Odhekar's resignation as Additional Executive DirectorAspira Pathlab & Diagnostics Limited confirmed that Vaibhav Odhekar resigned as Additional Executive Director on July 25, 2026, citing personal reasons. The resignation was disclosed in compliance with SEBI LODR Regulation 30. The company has not yet announced whether it will appoint an interim director or redistribute Odhekar's responsibilities.Business StandardAspira Pathlab & Diagnostics reports standalone net loss of Rs 0.69 crore in the March 2026 quarterAspira Pathlab & Diagnostics reported a standalone net loss of Rs 0.69 crore in the March 2026 quarter, despite a 12.80% increase in sales to Rs 6.52 crore. For the full year, the company's net profit declined significantly by 97.58% to Rs 0.05 crore, with a year-on-year sales increase of 13.55%.Financial ExpressAspira Pathlab & Diagnostics Share Price Today: Aspira Pathlab & Diagnostics Stock Price Live NSE/BSE, Aspira Pathlab & Diagnostics Share Price, Performance, Share Price Returns, HoldingsThe article reports the current stock performance of Aspira Pathlab & Diagnostics, including its share price, recent financials, and technical analysis. The company's stock has shown significant positive returns over various periods and remains actively traded.Business StandardAspira Pathlab & Diagnostics reports standalone net loss of Rs 1.56 crore in the December 2025 quarterAspira Pathlab & Diagnostics reported a standalone net loss of Rs 1.56 crore for the quarter ended December 2025, a reversal from a net profit of Rs 0.38 crore in the same quarter of 2024. Sales declined 5.36% year-over-year to Rs 5.12 crore from Rs 5.41 crore. Operating profit margin also turned negative at -23.63% compared to 14.23% in the prior year period.